Stock Comparison
ABBV vs JNJ
AbbVie Inc and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$626.01B
P/E (TTM)
70.3
30.1
Forward P/E
17.7
22.3
Price/Sales
6.8
6.4
Price/Book
51.1
7.4
EV/EBITDA
25.8
19.3
Dividend Yield
2.03%
2.00%
Profitability
Net Margin
9.82%
21.83%
Operating Margin
29.77%
26.87%
Return on Equity
62.30%
25.70%
Return on Assets
10.50%
8.60%
Growth (YoY)
Revenue Growth
10.20%
6.60%
Earnings Growth
290.40%
-0.90%
Price & Risk
Beta
0.3
0.2
52-Week High
$263.65
$267.34
52-Week Low
$197.38
$170.46
Analyst Target
$274.36
$272.50
Compare ABBV and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.